CH Biotech R&D Co (TPE:6534) Change In Payables And Accrued Expense : NT$0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is CH Biotech R&D Co Change In Payables And Accrued Expense?

CH Biotech R&D Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was NT$0 Mil. It means CH Biotech R&D Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

CH Biotech R&D Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was NT$0 Mil. It means CH Biotech R&D Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

CH Biotech R&D Co Change In Payables And Accrued Expense Historical Data

The historical data trend for CH Biotech R&D Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CH Biotech R&D Co Change In Payables And Accrued Expense Chart

CH Biotech R&D Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

CH Biotech R&D Co Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

CH Biotech R&D Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

CH Biotech R&D Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of CH Biotech R&D Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CH Biotech R&D Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » CH Biotech R&D Co Ltd (TPE:6534) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 89, Wenxian Road, Nantou County, Nantou, TWN, 540001

Website

https://www.chbio.com.tw

CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.

CH Biotech R&D Co Headlines

No Headlines